miRview® lung is a cutting-edge molecular diagnostic test that uses microRNA to differentiate between SCLC, carcinoid, squamous NSCLC and non-squamous NSCLC. The test offers unsurpassed accuracy, specificity, and sensitivity. Based on an extensive validation study, miRview® lung demonstrated 93.7% sensitivity and 98% specificity for the diagnosis of lung cancer¹.

1. Data on file, Rosetta Genomics.